000 | 01861 a2200553 4500 | ||
---|---|---|---|
005 | 20250515164136.0 | ||
264 | 0 | _c20090729 | |
008 | 200907s 0 0 eng d | ||
022 | _a0041-1345 | ||
024 | 7 |
_a10.1016/j.transproceed.2009.01.018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchneeberger, S | |
245 | 0 | 0 |
_aAlemtuzumab: key for minimization of maintenance immunosuppression in reconstructive transplantation? _h[electronic resource] |
260 |
_bTransplantation proceedings _cMar 2009 |
||
300 |
_a499-502 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAlemtuzumab |
650 | 0 | 4 | _aAmputation, Surgical |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aAntibodies, Neoplasm _xtherapeutic use |
650 | 0 | 4 |
_aArm _xtransplantation |
650 | 0 | 4 | _aAustria |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aForearm _xsurgery |
650 | 0 | 4 | _aFunctional Laterality |
650 | 0 | 4 | _aHand Transplantation |
650 | 0 | 4 | _aHistocompatibility Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlastic Surgery Procedures _xmethods |
650 | 0 | 4 | _aSpain |
650 | 0 | 4 | _aTransplantation Immunology |
650 | 0 | 4 |
_aTransplantation, Homologous _ximmunology |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aLandin, L | |
700 | 1 | _aKaufmann, C | |
700 | 1 | _aGorantla, V S | |
700 | 1 | _aBrandacher, G | |
700 | 1 | _aCavadas, P | |
700 | 1 | _aLee, W P A | |
700 | 1 | _aBreidenbach, W C | |
700 | 1 | _aMargreiter, R | |
773 | 0 |
_tTransplantation proceedings _gvol. 41 _gno. 2 _gp. 499-502 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2009.01.018 _zAvailable from publisher's website |
999 |
_c18765523 _d18765523 |